Company Proteomics International Laboratories Ltd
Equities
PIQ
AU000000PIQ0
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.885 AUD | -1.12% |
|
-5.85% | -1.12% |
24/06 | Proteomics International Laboratories Taps French Distributor for Diabetic Kidney Disease Test | MT |
18/06 | Proteomics International Issues 3.04 Million Options to Employees; Shares Up 7% | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Analytical Services
98.0
%
| - | - | 1 | 98.0 % | - |
Licensing
2.0
%
| - | - | 0 | 2.0 % | - |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia and New Zealand
80.9
%
| 1 | 81.7 % | 1 | 80.9 % | -51.45% |
United States
12.4
%
| 0 | 10.4 % | 0 | 12.4 % | -41.46% |
India
4.9
%
| 0 | 0.4 % | 0 | 4.9 % | +478.20% |
Europe
1.7
%
| 0 | 7.3 % | 0 | 1.7 % | -88.42% |
Southeast Asia
0.0
%
| 0 | 0.1 % | 0 | 0.0 % | -94.20% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 09/14/09 | |
Jacqueline Gray
DFI | Director of Finance/CFO | - | 12/21/12 |
Kirsten Peters
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bringans Scott
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael LeFauve
PRN | Corporate Officer/Principal | - | - |
Vik Malik
PRN | Corporate Officer/Principal | - | 01/21/01 |
Pearl Tan
PRN | Corporate Officer/Principal | - | 01/13/01 |
John Morrison
PRN | Corporate Officer/Principal | - | - |
Karen Logan
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul House
BRD | Director/Board Member | - | 22/17/22 |
Robyn Elliott
BRD | Director/Board Member | 63 | 16/21/16 |
Founder | - | 09/14/09 | |
Ian Moore
BRD | Director/Board Member | - | 14/16/14 |
Neville Gardiner
CHM | Chairman | - | 16/21/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 122,334,721 | 90,367,126 ( 73.87 %) | 0 | 73.87 % |
Company contact information
Proteomics International Laboratories Ltd.
QEII Medical Centre 6 Verdun Street
6009, Perth
+
http://www.proteomics.com.au![address Proteomics International Laboratories Ltd(PIQ)](https://cdn.zonebourse.com/static/address/18474992.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.12% | 7.8Cr | |
+16.73% | 12TCr | |
+21.13% | 11TCr | |
+18.05% | 2.59TCr | |
-17.94% | 2.09TCr | |
-16.24% | 1.65TCr | |
-11.76% | 1.68TCr | |
-44.45% | 1.56TCr | |
+69.92% | 1.55TCr | |
+1.41% | 1.34TCr |
- Stock Market
- Equities
- PIQ Stock
- Company Proteomics International Laboratories Ltd